Lactobacillus brevis SBC8803 and Modulated Inflammatory Response

• Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.

  • 2015-09-01
  • Review
  • International journal of molecular sciences 16(9)
  • • Eddy Owaga
    • Rong-Hong Hsieh
    • Beatrice Mugendi
    • Sakhile Masuku
    • Chun-Kuang Shih
    • Jung-Su Chang

  • PubMed: 26340622
  • DOI: 10.3390/ijms160920841

  2 Insights on

  • Modulated Inflammatory Response

  • Moderate evidence
  • Rigorous Journal

  there is mounting evidence of probiotics selectively targeting the Th17 lineage in the prevention and management of inflammatory and autoimmune diseases such as IBD... the rationale for using probiotics as a novel therapeutic approach for IBD through manipulation of Th17 cells.

  Effect

  Beneficial

  Effect size

  Moderate